# Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies

> **NCT03954691** · — · UNKNOWN · sponsor: **Neuromed IRCCS** · enrollment: 50 (estimated)

## Conditions studied

- Cancer of Head and Neck

## Interventions

- **OTHER:** brain tumor-immune cells communication

## Key facts

- **NCT ID:** NCT03954691
- **Lead sponsor:** Neuromed IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-01
- **Primary completion:** 2020-04-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954691, "Targeting Potassium Channels to Reprogram Glioblastoma Microenvironment: in Vitro and in Vivo Studies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03954691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*